| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c7a150b873b938820d7c456fe7a9ab4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
1986-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1989-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95cd9103ad5406858e881566145ca846 |
| publicationDate |
1989-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4886795-A |
| titleOfInvention |
Treatment and prevention of retinal edema with dopaminergic antagonists |
| abstract |
Retinal edema, in particular cystoid macular edema, is prevented or treated by administering to the patient afflicted with retinal edema or in danger of experiencing retinal edema an amount of a dopaminergic antagonist effective to reduce the edema. The activity of the dopaminergic antagonist may be potentiated by concurrent administration of ascorbic acid. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5266580-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5252568-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5252607-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017020891-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11033554-B2 |
| priorityDate |
1984-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |